Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Holdings Boosted by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 713.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,866 shares of the company's stock after buying an additional 97,235 shares during the quarter. SG Americas Securities LLC owned about 0.12% of Acadia Healthcare worth $4,396,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. State Street Corp lifted its holdings in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company's stock worth $178,811,000 after buying an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after acquiring an additional 454,044 shares in the last quarter. LMR Partners LLP purchased a new position in Acadia Healthcare in the third quarter valued at $1,616,000. Principal Financial Group Inc. increased its position in shares of Acadia Healthcare by 2.1% in the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company's stock valued at $41,653,000 after purchasing an additional 13,368 shares during the last quarter. Finally, Sivik Global Healthcare LLC increased its holdings in Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company's stock valued at $7,292,000 after buying an additional 34,997 shares during the last quarter.

Wall Street Analyst Weigh In

Several brokerages recently commented on ACHC. Royal Bank of Canada reiterated an "outperform" rating and set a $64.00 price target on shares of Acadia Healthcare in a research note on Friday, January 10th. TD Cowen reduced their target price on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a report on Tuesday, January 7th. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. KeyCorp upgraded Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 price objective for the company in a research note on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $70.22.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded down $0.32 during midday trading on Friday, hitting $44.18. 1,204,528 shares of the stock were exchanged, compared to its average volume of 1,741,804. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a 50 day moving average price of $41.15 and a 200-day moving average price of $56.43. The stock has a market cap of $4.10 billion, a P/E ratio of 14.49, a PEG ratio of 1.79 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the company earned $0.91 EPS. Acadia Healthcare's revenue was up 8.7% on a year-over-year basis. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.39 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.